Preventive effect of ipragliflozin on nocturnal hypoglycemia in patients with type 2 diabetes treated with basal-bolus insulin therapy: An open-label, single-center, parallel, randomized control study-Reference-Cited by-同舟云学术

Preventive effect of ipragliflozin on nocturnal hypoglycemia in patients with type 2 diabetes treated with basal-bolus insulin therapy: An open-label, single-center, parallel, randomized control study

Published:2016-11-25 Issue:3 Volume:8 Page:341-345
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Okajima Fumitaka¹²^ORCID,Nagamine Tomoko¹²,Nakamura Yuko¹²,Hattori Naomi¹²,Sugihara Hitoshi²,Emoto Naoya¹²

Affiliation:

1. Division of Endocrinology; Department of Medicine; Chiba-Hokusoh Hospital; Nippon Medical School; Chiba Japan

2. Department of Endocrinology; Diabetes and Metabolism; Graduate School of Medicine; Nippon Medical School; Tokyo Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12588/fullpdf

Reference18 articles.

1. Update on insulin therapy for type 2 diabetes;Donner;J Clin Endocrinol Metab,2012

2. Effect of glycemic control on chylomicron metabolism and correlation between postprandial metabolism of plasma glucose and chylomicron in patients with type 2 diabetes treated with basal-bolus insulin therapy with or without Vildagliptin;Okajima;J Atheroscler Thromb,2016

3. Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy;Shimoda;Endocr J,2013

4. Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibition;Rajeev;Diabetes Obes Metab,2016

5. Investigators E-RO: Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes;Zinman;N Engl J Med,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extraction, Characterization, and In Vitro Hypoglycemic Activity of a Neutral Polysaccharide from the New Medicinal Mushroom Cantharellus yunnanensis (Agaricomycetes);International Journal of Medicinal Mushrooms;2023

2. Sodium–glucose cotransporter 2 inhibitors improved time‐in‐range without increasing hypoglycemia in Japanese patients with type 1 diabetes: A retrospective, single‐center, pilot study;Journal of Diabetes Investigation;2020-03-27

3. Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians;Journal of Diabetes Investigation;2019-10-14

4. Efficacy and Safety of Tofogliflozin on 24-h Glucose Profile Based on Continuous Glucose Monitoring: Crossover Study of Sodium–Glucose Cotransporter 2 Inhibitor;Diabetes Technology & Therapeutics;2019-07

5. Addition of canagliflozin to insulin improves glycaemic control and reduces insulin dose in patients with type 2 diabetes mellitus: A randomized controlled trial;Diabetes, Obesity and Metabolism;2019-06-11